Charles River Laboratories International, Inc. (CRL)
NYSE·Healthcare·Medical - Diagnostics & Research
$376.76
+5.01%
Mkt Cap $16.61B
Analyst Ratings
Buy
19
Hold
3
Sell
0
Price Target (53 analysts)
$282.36
Range $219.00 – $330.00
Implied Upside
-25.1%
Consensus $282.36 vs current $376.76